SPIN Unprocessed October 14, 2026 ai_technology technology
Intero Biosystems wants drugmakers to test on mini human intestines, not animals
View original on techcrunch.comOverview
Intero Biosystems is selling lab-grown human intestines to drugmakers as regulators push for alternatives to animal testing, while the startup looks to scale production and expand its organoid technology.
SpinGraph analysis pending — check back after processing.
Ask AI about this story
Opens with the SpinGraph .md URL and structured context — one click, prompt included.
More from TechCrunch
View all →- Meet the five companies competing in the Startup Battlefield finals at Disrupt 2026
- Flock CEO defends surveillance technology amid national backlash: ‘We shouldn’t pause progress’
- Ricursive Intelligence is betting on AI-designed chips to help solve the compute crisis
- Figma announces new features to define how agents work on its platform
- YouTube Music launches new labels as AI-generated music floods streaming platforms
- Hiyd is a health tracker that attaches to the watch you already wear
Markdown (.md) · JSON-LD schema (.json) · Machine-readable for AI & GEO